Expertise in
42
conditions

Dr. Julie Silverstein

Endocrinology
Office
4500 Forest Park Ave Fl 1, 
Saint Louis, MO 
Offers Telehealth
Referral may be required
Expertise in
42
conditions
Office
4500 Forest Park Ave Fl 1, 
Saint Louis, MO 

Overview

Julie Silverstein is an Endocrinologist practicing medicine in Saint Louis, Missouri.

Dr. Silverstein is highly rated in 42 conditions, according to our data. Her clinical expertise encompasses Pituitary Tumor, Cushing's disease, Acromegaly, Hypothalamic Tumor, and Endoscopic Transnasal Transsphenoidal Surgery.

She is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 5 clinical trials.

Specialties

Endocrinology

Licenses

Internal Medicine in MO

Hospital Affiliations

Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Missouri Baptist Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Home State Health
  • EPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MetLife
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Office
4500 Forest Park Ave Fl 1, Saint Louis, MO 63108

Additional Areas of Focus

Dr. Silverstein has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control
A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control
Enrollment Status: Suspended
Publish Date: November 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: June 19, 2025
Intervention Type: Drug
Study Drug: Levoketoconazole
Study Phase: Phase 3
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
Enrollment Status: Completed
Publish Date: May 29, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

26 Total Publications

Multi-center comparison of corticotropin releasing hormone vs. desmopressin stimulation responses in inferior petrosal sinus sampling for Cushing's disease.
Multi-center comparison of corticotropin releasing hormone vs. desmopressin stimulation responses in inferior petrosal sinus sampling for Cushing's disease.
Journal: Clinical neurology and neurosurgery
Published: March 01, 2026
Similar Doctors
Expertise in
10
conditions
Dr. Sandeep Dhindsa
Endocrinology
Expertise in
10
conditions
Dr. Sandeep Dhindsa
Endocrinology
Referral may be required

SLUCare Physician Group

1225 S. Grand Blvd., Second Level, 
St. Louis, MO 
 (1.7 miles away)
314-617-2655
Languages Spoken:
English
See accepted insurances

Dr. Sandeep Dhindsa is an endocrinology specialist who treats conditions that include diabetes, low testosterone, thyroid, pituitary and adrenal disorders. His primary area of research is in the field of hypogonadism and type 2 diabetes. He has shown that one-third of men with diabetes and obesity have low testosterone. He is studying the role of testosterone in insulin resistance and diabetes control. Dr. Dhindsa is a professor in the Department of Internal Medicine and serves as the director of the Division of Endocrinology, Diabetes and Metabolism at Saint Louis University School of Medicine. He is a member of the American Diabetes Association and the Endocrine Society. A fellow of the American Association of Clinical Endocrinologists, Dr. Dhindsa is also a member of the Scientific Reproductive Committee of that organization. Dr. Dhindsa is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Hypogonadotropic Hypogonadism, Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Hormone Replacement Therapy (HRT), and Gastric Bypass. Dr. Dhindsa is board certified in American Board Of Internal Medicine/Endocrinology, Diabetes & Metabolism , Drug Enforcement Administration , Missouri Dept Of Health/Narcotics&Dangerous Drugs , and Missouri State Board Of Registration.

Expertise in
6
conditions
Dr. Fumihiko Urano
Endocrinology
Expertise in
6
conditions
Dr. Fumihiko Urano
Endocrinology
Referral may be required

Washington University

4921 Parkview Pl, 
Saint Louis, MO 
 (0.2 miles away)
Languages Spoken:
English
See accepted insurances

Fumihiko Urano is an Endocrinologist practicing medicine in Saint Louis, Missouri. Dr. Urano is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Wolfram Syndrome, Diabetes Insipidus (DI), Neurohypophyseal Diabetes Insipidus, and Melasma.

Expertise in
13
conditions
Dr. Sina Jasim
Endocrinology
Expertise in
13
conditions
Dr. Sina Jasim
Endocrinology
Referral may be required

Office

4500 Forest Park Ave Fl 1, 
Saint Louis, MO 
 (0.9 miles away)
314-362-3500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sina Jasim is an Endocrinologist practicing medicine in Saint Louis, Missouri. Dr. Jasim is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Hormone Replacement Therapy (HRT), and Tissue Biopsy.

Frequently Asked Questions about Dr. Julie Silverstein

How do I make an appointment with Dr. Julie Silverstein?

You can book an appointment with Dr. Julie Silverstein by calling their office at 314-362-3500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Julie Silverstein a top-rated expert for Pituitary Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Julie Silverstein is classified as an Elite expert for Pituitary Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Julie Silverstein specialize in?

While Dr. Julie Silverstein is a Endocrinology, they have specific expertise in Pituitary Tumor, Cushing's disease, and Acromegaly. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Julie Silverstein participate in research or clinical trials?

Yes. Dr. Julie Silverstein has published 26 articles and abstracts on conditions like Pituitary Tumor. You can view a list of Dr. Julie Silverstein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Julie Silverstein accept my insurance?

Dr. Julie Silverstein accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-362-3500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Silverstein's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 31 Advanced Conditions
View All 29 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile